PHASE 2A, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND EFFICACY OF BTRX-246040 IN PARKINSON'S DISEASE SUBJECTS WITH MOTOR FLUCTUATIONS ( PROTOCOL NEP-PD-201)

Administered By

Awarded By

Contributors

Start/End

  • September 14, 2018 - November 27, 2019